(DAILYMAIL) — The first Ebola vaccine could be available in two to six years, experts say but warn a lack of funding could hamper vital clinical trials.
At least four new drugs are in the developmental stage in labs across the U.S. with trials involving primates yielding positive results.
But researchers warn a lack of funding threatens the speed at which the first preventative jab could be available for human use.
Advertisement - story continues below
Dr Thomas Geisbert of the University of Texas said he believes a vaccine will be approved in the next two to six years.